FER1L5
gene geneOn this page
Also known as DKFZp434I0121
Summary
FER1L5 (fer-1 like family member 5, HGNC:19044) is a protein-coding gene on chromosome 2q11.2, encoding Fer-1-like protein 5 (A0AVI2). Plays a crucial role in male fertility, primarily through its involvement in the acrosome reaction of spermatozoa.
Predicted to enable calcium ion binding activity. Predicted to be involved in regulation of neurotransmitter secretion. Predicted to be located in plasma membrane. Predicted to be active in synaptic vesicle membrane.
Source: NCBI Gene 90342 — RefSeq curated summary.
At a glance
- GWAS associations: 12
- Clinical variants (ClinVar): 304 total
- MANE Select transcript:
NM_001293083
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:19044 |
| Approved symbol | FER1L5 |
| Name | fer-1 like family member 5 |
| Location | 2q11.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DKFZp434I0121 |
| Ensembl gene | ENSG00000249715 |
| Ensembl biotype | protein_coding |
| OMIM | 620883 |
| Entrez | 90342 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 2 retained_intron, 2 protein_coding
ENST00000457909, ENST00000505256, ENST00000623019, ENST00000624922
RefSeq mRNA: 1 — MANE Select: NM_001293083
NM_001293083
CCDS: CCDS77438
Canonical transcript exons
ENST00000624922 — 53 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003755000 | 96647064 | 96647155 |
| ENSE00003755143 | 96696052 | 96696077 |
| ENSE00003755149 | 96685940 | 96686117 |
| ENSE00003755253 | 96668751 | 96668794 |
| ENSE00003755367 | 96701955 | 96702043 |
| ENSE00003755520 | 96691445 | 96691612 |
| ENSE00003755643 | 96692104 | 96692181 |
| ENSE00003755677 | 96673077 | 96673254 |
| ENSE00003755825 | 96668886 | 96668968 |
| ENSE00003756178 | 96654446 | 96654496 |
| ENSE00003756324 | 96650180 | 96650289 |
| ENSE00003756351 | 96698037 | 96698156 |
| ENSE00003756402 | 96700332 | 96700471 |
| ENSE00003756432 | 96653640 | 96653702 |
| ENSE00003756452 | 96702306 | 96702401 |
| ENSE00003756519 | 96697660 | 96697761 |
| ENSE00003756647 | 96697526 | 96697576 |
| ENSE00003756743 | 96660341 | 96660371 |
| ENSE00003756918 | 96663439 | 96663507 |
| ENSE00003757191 | 96670119 | 96670247 |
| ENSE00003757455 | 96695742 | 96695904 |
| ENSE00003757564 | 96690487 | 96690589 |
| ENSE00003757604 | 96689644 | 96689758 |
| ENSE00003757617 | 96651892 | 96652020 |
| ENSE00003757620 | 96685329 | 96685429 |
| ENSE00003758049 | 96684327 | 96684451 |
| ENSE00003758072 | 96662215 | 96662267 |
| ENSE00003758177 | 96699550 | 96699720 |
| ENSE00003758459 | 96694360 | 96694464 |
| ENSE00003758550 | 96702978 | 96703077 |
| ENSE00003758661 | 96647778 | 96647886 |
| ENSE00003758691 | 96691190 | 96691353 |
| ENSE00003758783 | 96702600 | 96702741 |
| ENSE00003758963 | 96704215 | 96704362 |
| ENSE00003759194 | 96691825 | 96691963 |
| ENSE00003759209 | 96649623 | 96649677 |
| ENSE00003759296 | 96669043 | 96669137 |
| ENSE00003759378 | 96687816 | 96687947 |
| ENSE00003759564 | 96699932 | 96700080 |
| ENSE00003759621 | 96686195 | 96686350 |
| ENSE00003759654 | 96646401 | 96646453 |
| ENSE00003759734 | 96695509 | 96695661 |
| ENSE00003759789 | 96703523 | 96703632 |
| ENSE00003759808 | 96703153 | 96703346 |
| ENSE00003759881 | 96661668 | 96661791 |
| ENSE00003759934 | 96698671 | 96698832 |
| ENSE00003760005 | 96661325 | 96661440 |
| ENSE00003760034 | 96693911 | 96694072 |
| ENSE00003760076 | 96689213 | 96689376 |
| ENSE00003760120 | 96693506 | 96693687 |
| ENSE00003760123 | 96699045 | 96699136 |
| ENSE00003814043 | 96704468 | 96704883 |
| ENSE00003845087 | 96642764 | 96642921 |
Expression profiles
Bgee: expression breadth ubiquitous, 125 present calls, max score 85.81.
FANTOM5 (CAGE): breadth broad, TPM avg 0.4405 / max 32.9292, expressed in 216 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 21477 | 0.4405 | 216 |
Top tissues by expression
230 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 85.81 | gold quality |
| right testis | UBERON:0004534 | 78.67 | gold quality |
| left testis | UBERON:0004533 | 78.50 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 78.18 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 78.14 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 77.47 | silver quality |
| testis | UBERON:0000473 | 75.54 | gold quality |
| pancreatic ductal cell | CL:0002079 | 73.44 | silver quality |
| body of pancreas | UBERON:0001150 | 70.02 | gold quality |
| ileal mucosa | UBERON:0000331 | 69.68 | gold quality |
| tibialis anterior | UBERON:0001385 | 69.37 | silver quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 66.08 | gold quality |
| myocardium | UBERON:0002349 | 63.89 | gold quality |
| right uterine tube | UBERON:0001302 | 62.80 | gold quality |
| pancreas | UBERON:0001264 | 62.66 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 61.89 | gold quality |
| deltoid | UBERON:0001476 | 60.88 | silver quality |
| adenohypophysis | UBERON:0002196 | 59.15 | gold quality |
| ventricular zone | UBERON:0003053 | 58.51 | gold quality |
| nucleus accumbens | UBERON:0001882 | 58.50 | gold quality |
| putamen | UBERON:0001874 | 58.31 | gold quality |
| caudate nucleus | UBERON:0001873 | 58.28 | gold quality |
| pituitary gland | UBERON:0000007 | 57.71 | gold quality |
| colonic epithelium | UBERON:0000397 | 57.10 | gold quality |
| metanephros cortex | UBERON:0010533 | 56.89 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 56.17 | gold quality |
| metanephros | UBERON:0000081 | 55.27 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 55.17 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 54.20 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 54.08 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.63 |
Regulation
Is transcription factor: no
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Fer1l5 | ENSMUSG00000037432 |
| rattus_norvegicus | Fer1l5 | ENSRNOG00000024201 |
| drosophila_melanogaster | mfr | FBGN0266757 |
| caenorhabditis_elegans | fer-1 | WBGENE00001414 |
Paralogs (4): OTOF (ENSG00000115155), DYSF (ENSG00000135636), MYOF (ENSG00000138119), FER1L6 (ENSG00000214814)
Protein
Protein identifiers
Fer-1-like protein 5 — A0AVI2 (reviewed: A0AVI2)
All UniProt accessions (2): A0AVI2, A0A286YFD1
UniProt curated annotations — full annotation on UniProt →
Function. Plays a crucial role in male fertility, primarily through its involvement in the acrosome reaction of spermatozoa. Required for the Ca(2+)-activated fusion of the acrosomal membrane with the plasma membrane during the acrosome. May play a role in skeletal muscle cell development by ensuring effective myoblast fusion and facilitating membrane repair.
Subunit / interactions. Interacts (via second C2 domain) with EHD1 and EHD2. Interacts with STX2.
Subcellular location. Cell membrane. Cytoplasmic vesicle membrane.
Cofactor. Binds 3 Ca(2+) ions per C2 domain.
Miscellaneous. Gene prediction based on partial mRNA data.
Similarity. Belongs to the ferlin family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| A0AVI2-1 | 1 | yes |
| A0AVI2-2 | 2 | |
| A0AVI2-4 | 3 |
RefSeq proteins (1): NP_001280012* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000008 | C2_dom | Domain |
| IPR006614 | Peroxin/Ferlin | Domain |
| IPR012560 | Ferlin_A-domain | Domain |
| IPR012561 | Ferlin_B-domain | Domain |
| IPR012968 | FerIin_dom | Domain |
| IPR032362 | Ferlin_C | Domain |
| IPR035892 | C2_domain_sf | Homologous_superfamily |
| IPR037720 | C2B_Ferlin | Domain |
| IPR037721 | Ferlin | Family |
| IPR037723 | C2D_Ferlin | Domain |
| IPR037724 | C2E_Ferlin | Domain |
| IPR037725 | C2F_Ferlin | Domain |
| IPR037726 | C2A_Ferlin | Domain |
| IPR055072 | Ferlin_DSRM | Domain |
Pfam: PF00168, PF08150, PF08165, PF16165, PF22901
UniProt features (30 total): binding site 15, domain 7, topological domain 2, splice variant 2, sequence variant 2, chain 1, transmembrane region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A0AVI2-F1 | 74.71 | 0.11 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (15): 1502; 1502; 1508; 1557; 1557; 1558; 1559; 1559; 1559; 1562; 1565; 1565 …
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 57 (showing top):
GOBP_SINGLE_FERTILIZATION, GOBP_MEMBRANE_FUSION, GOBP_PLASMA_MEMBRANE_ORGANIZATION, GOBP_STRIATED_MUSCLE_CELL_DIFFERENTIATION, GOBP_NEUROTRANSMITTER_TRANSPORT, GOBP_CELL_CELL_SIGNALING, GOBP_WOUND_HEALING, GOBP_MUSCLE_STRUCTURE_DEVELOPMENT, GOBP_SPERM_EGG_RECOGNITION, GOBP_REGULATION_OF_NEUROTRANSMITTER_TRANSPORT, GOBP_SECRETION, GOBP_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM, GOBP_SIGNAL_RELEASE, GOBP_ENDOMEMBRANE_SYSTEM_ORGANIZATION, GOBP_SYNAPTIC_SIGNALING
GO Biological Process (5): plasma membrane repair (GO:0001778), membrane fusion involved in acrosome reaction (GO:0002078), binding of sperm to zona pellucida (GO:0007339), myoblast fusion (GO:0007520), regulation of neurotransmitter secretion (GO:0046928)
GO Molecular Function (2): calcium ion binding (GO:0005509), metal ion binding (GO:0046872)
GO Cellular Component (4): plasma membrane (GO:0005886), cytoplasmic vesicle membrane (GO:0030659), synaptic vesicle membrane (GO:0030672), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| plasma membrane organization | 1 |
| wound healing | 1 |
| acrosome reaction | 1 |
| cellular process involved in reproduction in multicellular organism | 1 |
| membrane fusion | 1 |
| sperm-egg recognition | 1 |
| syncytium formation by cell-cell fusion | 1 |
| myotube differentiation | 1 |
| neurotransmitter secretion | 1 |
| modulation of chemical synaptic transmission | 1 |
| regulation of neurotransmitter transport | 1 |
| regulation of secretion by cell | 1 |
| metal ion binding | 1 |
| cation binding | 1 |
| membrane | 1 |
| cell periphery | 1 |
| vesicle membrane | 1 |
| cytoplasmic vesicle | 1 |
| synaptic vesicle | 1 |
| exocytic vesicle membrane | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
596 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FER1L5 | EHD2 | Q9NZN4 | 737 |
| FER1L5 | EHD3 | Q9NZN3 | 683 |
| FER1L5 | EHD1 | Q9H4M9 | 539 |
| FER1L5 | FAHD2B | Q6P2I3 | 512 |
| FER1L5 | FAM178B | Q8IXR5 | 506 |
| FER1L5 | ANKRD39 | Q53RE8 | 505 |
| FER1L5 | TMEM253 | P0C7T8 | 448 |
| FER1L5 | LMAN2L | Q9H0V9 | 445 |
| FER1L5 | CNNM4 | Q6P4Q7 | 435 |
| FER1L5 | ITPRIPL1 | Q6GPH6 | 416 |
| FER1L5 | ARHGAP26 | Q9UNA1 | 404 |
| FER1L5 | EPS15 | P42566 | 403 |
| FER1L5 | EMG1 | Q92979 | 402 |
| FER1L5 | PKDREJ | Q9NTG1 | 401 |
| FER1L5 | ANKRD36 | A6QL64 | 370 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FER1L5 | H1-4 | psi-mi:“MI:0915”(physical association) | 0.400 |
| FER1L5 | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (5): HIST1H1E (Proximity Label-MS), FER1L5 (Proximity Label-MS), FER1L5 (Affinity Capture-RNA), FER1L5 (Proximity Label-MS), FER1L5 (Proximity Label-MS)
ESM2 similar proteins: A0AVI2, A0FGR9, A3KGK3, A6NCM1, A6QQP7, B0DOB4, B3DLH6, B7FF09, B7ZC32, D3ZGS3, F1S5L4, O00329, O35904, O70145, O75923, P0DM40, P32019, P58069, P97564, Q0VA04, Q15283, Q17I16, Q1LXZ7, Q2WGJ9, Q32PH0, Q5DTI8, Q5GJ77, Q5RE88, Q5T0N1, Q5XIZ9, Q61586, Q62240, Q63713, Q69ZN7, Q6DCF6, Q6P5U7, Q6PA97, Q86VS3, Q86YR7, Q8BWR4
Diamond homologs: A0AVI2, A3KGK3, A6QQP7, B3DLH6, O75923, P0DM40, Q69ZN7, Q8LFN9, Q9C6B7, Q9ESD7, Q9NZM1, Q9Z268, A0JJX5, B2RUP2, C9J798, O43374, O95294, P48231, Q2WGJ9, Q54E35, Q5SPC5, Q8L706, Q8L7A4, Q8W4D4, Q9ERC5, Q9ESF1, Q9FVJ3, Q9HC10, Q9R189, Q9UT00, A1ZBD6, B6ETT4, D4ABL6, E9PV86, K8FE10, O00445, O35681, P05128, P05129, P05130
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
304 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 263 |
| Likely benign | 27 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
9298 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:96647772:CCCCA:C | acceptor_loss | 1.0000 |
| 2:96647773:CCCA:C | acceptor_loss | 1.0000 |
| 2:96647775:CAG:C | acceptor_loss | 1.0000 |
| 2:96647776:A:AG | acceptor_gain | 1.0000 |
| 2:96647776:A:T | acceptor_loss | 1.0000 |
| 2:96647777:G:GG | acceptor_gain | 1.0000 |
| 2:96647777:G:GT | acceptor_loss | 1.0000 |
| 2:96647884:GAT:G | donor_gain | 1.0000 |
| 2:96647887:G:GG | donor_gain | 1.0000 |
| 2:96647902:G:GT | donor_gain | 1.0000 |
| 2:96649621:A:AG | acceptor_gain | 1.0000 |
| 2:96649622:G:GA | acceptor_gain | 1.0000 |
| 2:96649622:GT:G | acceptor_gain | 1.0000 |
| 2:96649622:GTGT:G | acceptor_gain | 1.0000 |
| 2:96649622:GTGTA:G | acceptor_gain | 1.0000 |
| 2:96649673:GACAG:G | donor_gain | 1.0000 |
| 2:96649674:ACAGG:A | donor_loss | 1.0000 |
| 2:96649677:GGT:G | donor_loss | 1.0000 |
| 2:96649679:T:G | donor_loss | 1.0000 |
| 2:96650179:GGA:G | acceptor_gain | 1.0000 |
| 2:96651887:CTTA:C | acceptor_loss | 1.0000 |
| 2:96651888:TTA:T | acceptor_loss | 1.0000 |
| 2:96651890:A:AG | acceptor_gain | 1.0000 |
| 2:96651890:A:AT | acceptor_loss | 1.0000 |
| 2:96651891:G:GG | acceptor_gain | 1.0000 |
| 2:96651891:GGTTC:G | acceptor_gain | 1.0000 |
| 2:96651994:A:G | donor_gain | 1.0000 |
| 2:96651998:G:T | donor_gain | 1.0000 |
| 2:96654497:G:GG | donor_gain | 1.0000 |
| 2:96661793:T:G | donor_gain | 1.0000 |
AlphaMissense
13633 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:96703305:T:A | W1884R | 0.997 |
| 2:96703305:T:C | W1884R | 0.997 |
| 2:96699948:T:A | W1600R | 0.995 |
| 2:96699948:T:C | W1600R | 0.995 |
| 2:96661397:T:C | L284P | 0.994 |
| 2:96663478:T:A | W371R | 0.993 |
| 2:96663478:T:C | W371R | 0.993 |
| 2:96670162:G:C | R469P | 0.993 |
| 2:96698152:T:C | F1451S | 0.993 |
| 2:96698678:T:C | F1455S | 0.993 |
| 2:96698780:G:C | R1489P | 0.993 |
| 2:96702317:G:C | R1724P | 0.993 |
| 2:96698156:G:C | K1452N | 0.992 |
| 2:96698156:G:T | K1452N | 0.992 |
| 2:96703542:T:C | L1904P | 0.992 |
| 2:96701970:T:A | W1696R | 0.991 |
| 2:96701970:T:C | W1696R | 0.991 |
| 2:96703302:T:A | W1883R | 0.991 |
| 2:96703302:T:C | W1883R | 0.991 |
| 2:96703307:G:C | W1884C | 0.991 |
| 2:96703307:G:T | W1884C | 0.991 |
| 2:96661345:T:A | W267R | 0.990 |
| 2:96661345:T:C | W267R | 0.990 |
| 2:96673170:A:C | S529R | 0.990 |
| 2:96673172:C:A | S529R | 0.990 |
| 2:96673172:C:G | S529R | 0.990 |
| 2:96699591:T:C | L1551P | 0.990 |
| 2:96689336:T:A | W829R | 0.989 |
| 2:96689336:T:C | W829R | 0.989 |
| 2:96699950:G:C | W1600C | 0.989 |
dbSNP variants (sampled 300 via entrez): RS1000011491 (2:96653092 C>A), RS1000053354 (2:96696797 A>C,G), RS1000075546 (2:96703997 G>A), RS1000101200 (2:96670501 G>A), RS1000102953 (2:96658190 G>A,T), RS1000147969 (2:96654948 C>A), RS1000183365 (2:96681881 G>A), RS1000223944 (2:96705098 G>A), RS1000253212 (2:96652872 G>A), RS1000311469 (2:96646297 C>A,G,T), RS1000364834 (2:96646136 C>T), RS1000422617 (2:96674546 T>A), RS1000426136 (2:96687533 C>T), RS1000446542 (2:96652923 C>A), RS1000452214 (2:96674155 T>C)
Disease associations
OMIM: gene MIM:620883 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
12 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001241_9 | Bipolar disorder | 2.000000e-06 |
| GCST003962_1 | Bipolar disorder | 3.000000e-10 |
| GCST006166_50 | Diastolic blood pressure x alcohol consumption interaction (2df test) | 3.000000e-10 |
| GCST006166_84 | Diastolic blood pressure x alcohol consumption interaction (2df test) | 1.000000e-11 |
| GCST006190_24 | Diastolic blood pressure x smoking status (ever vs never) interaction (2df test) | 2.000000e-11 |
| GCST006190_31 | Diastolic blood pressure x smoking status (ever vs never) interaction (2df test) | 2.000000e-11 |
| GCST006193_15 | Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test) | 2.000000e-12 |
| GCST006193_55 | Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test) | 4.000000e-13 |
| GCST006865_6 | Bipolar disorder | 3.000000e-06 |
| GCST007094_109 | Diastolic blood pressure | 1.000000e-07 |
| GCST008103_13 | Bipolar disorder | 4.000000e-09 |
| GCST90020028_63 | Hip circumference adjusted for BMI | 7.000000e-09 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004329 | alcohol drinking |
| EFO:0006336 | diastolic blood pressure |
| EFO:0006527 | smoking status measurement |
| EFO:0008039 | BMI-adjusted hip circumference |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
13 total (human), top 13 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aminomethylphosphonic acid (AMPA) | decreases expression | 1 |
| ethyl-p-hydroxybenzoate | decreases expression | 1 |
| licochalcone B | increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Copper | affects cotreatment, decreases expression | 1 |
| Phthalic Acids | increases methylation | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| 2,4-Dichlorophenoxyacetic Acid | decreases expression | 1 |
| Cadmium Chloride | increases expression | 1 |
| Acrylamide | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.